Home > Boards > US OTC > Medical - Drugs > Innovation Pharmaceuticals Inc. (IPIX)

Foam or gel enemas for UP would be

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
KarinCA Member Profile
Member Level 
Followed By 541
Posts 24,564
Boards Moderated 2
Alias Born 11/16/07
160x600 placeholder
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 8/13/2019 4:11:11 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 8/2/2019 4:29:30 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/22/2019 9:30:41 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/16/2019 10:16:34 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2019 5:19:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/10/2019 7:33:24 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/10/2019 7:32:13 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/8/2019 4:05:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/31/2019 4:18:06 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/31/2019 4:17:16 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/22/2019 12:08:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/7/2019 4:32:21 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/18/2018 5:02:33 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/17/2018 7:07:54 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/17/2018 7:02:14 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/13/2018 7:16:54 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/8/2018 5:03:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/24/2018 7:01:54 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/16/2018 4:17:40 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/15/2018 6:20:16 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/10/2018 10:56:48 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/9/2018 6:54:26 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 10/9/2018 6:53:37 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/24/2018 4:36:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/24/2018 4:33:20 PM
KarinCA Member Level  Sunday, 06/02/19 05:39:45 PM
Re: loanranger post# 264889
Post # of 271013 
Foam or gel enemas for UP would be considered a local treatment to the site.
Quote:
BEVERLY, MA – May 16, 2019 (GLOBE NEWSWIRE) Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report that the Company has signed a non-binding term sheet with a global pharmaceutical company to develop and commercialize locally-administered Brilacidin (e.g., foam, enema, gel), on a worldwide basis, for the treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis.


An oral pill is another story.

Regarding your response to following
Quote:
Right now the company is in partnership discussions to further develop Brilacidin for local treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis. IBD is a huge world wide market. Hopefully IPIX can make a difference as they advance their pill form.






In Reply to 'loanranger'
local treatment?






To follow KarinCA, click here then click "Follow This Member" under my photo.

Be kinder than necessary, for everyone you meet is fighting some kind of battle.
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist